Search
for
Sort by
Research 931–960 of 1000+
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Pustular allergic contact dermatitis from topical minoxidil 5%
- Treatment of trichostasis spinulosa with 0.5-millisecond pulsed 755-nm alexandrite laser
- In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia
- Invalidation of a commercially available human 5α-dihydrotestosterone immunoassay
- Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men
- Treatment of androgenetic alopecia with a 7.5% herbal preparation
- Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
- Pathologic Quiz Case: An Anterior Neck Mass in a 5-Month-Old Female Infant
- Comparative GC-MS Based In vitro Assays of 5α-Reductase Activity Using Rat Liver S9 Fraction
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study
- Frontal edema due to topical application of %5 minoxidil solution following mesotherapy injections
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Effect of Solvent on Stereoselectivity in Pd/C (Type 39K)-Catalyzed Hydrogenation of Methyl 3-Oxo-4-aza-5-androstene-17-carboxylate, A Key Intermediate for Finasteride and Dutasteride
- Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study
- Exploring Variation in Ovine KRTAP19-5 and Its Effect on Fine Wool Fibre Curvature in Chinese Tan Sheep
- A Founder Mutation in the <i>POMC</i> 5′-UTR Causes Proopiomelanocortin Deficiency Through Splicing-Mediated Decrease of mRNA
- Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
- Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line.
- Comparative Study of Efficacy of Topical Minoxidil 5% and Combination of Topical Minoxidil 5%, Topical Azelaic Acid 1.5% and Topical Tretinoin 0.01% on the Basis of Dermoscopic Analysis in Androgenetic Alopecia
- The Benefits of Dual Inhibition of 5α Reductase
- The effects of garlic topical gel (5%) in the treatment of alopecia areata
- Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- Novel azaandrostane derivatives for the synthesis of 17β‐(<i>N</i>‐<i>tert</i>‐butyl carbamoyl)‐4‐aza‐5α‐androst‐1‐ene‐3‐one
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia